Delivery Order SPE2DB22D3501-SPE2DB24FXC04

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VIVITROL 380 mg vials and diluents. The contract, valued at $13,757.13, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical for delivery through April 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the provision of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,828.64 and a completion date of July 1, 2024. It is a firm-fixed price delivery order contract, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, holds a larger single-award Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, covers the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA). The contract, valued at $7,635.39, is a firm fixed-price delivery order with a period of performance through November 2023. The contract was awarded on November 22, 2023, and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The $3,270.58 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. Amerisourcebergen Drug Corp holds a single award indefinite delivery contract (IDC) with DLA, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical valued at $3,263.65. The award is for the supply of Vivitrol 380 mg vials and diluents, a specialty medication, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC)...
This federal contract award is for the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA), a defense agency. The $3,667.57 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 20, 2024, with a completion date of May 21, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,678.13 firm fixed-price delivery order is for the supply of 380 mg Vivitrol vials and diluents, a medication used for treating alcohol and opioid dependence. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order contract with the Defense Logistics Agency (DLA) valued at $9,006.04. The contract provides VIVITROL 380 MG VIAL-DILUENTS, which are specialty pharmaceutical products, to support military healthcare programs. The contract has an ultimate completion date of March 21, 2025 and is a Firm Fixed Price arrangement. This award is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,010.44 firm fixed-price delivery order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a specialty medication, to support military healthcare programs. The contract has a completion date of February 27, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,657.24 firm fixed-price contract is for the delivery of Vivitrol 380 mg vials and diluents. This delivery order is associated with Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a range of medical commodities to support military treatment programs and...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FXC04
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of Vivitrol 380 mg vials and diluents to the Defense Logistics Agency (DLA), a defense agency. The $3,657.24 firm fixed-price delivery order has a period of performance through September 2024 and is not set aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of medical commodities, including prescription drugs and specialty medications, to support military treatment programs and facilities worldwide. The company also has a $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and pharmaceuticals.

Generated 12/24/24, 9:22 AM